GB2031423A - Production of Heterocyclic Compounds - Google Patents

Production of Heterocyclic Compounds Download PDF

Info

Publication number
GB2031423A
GB2031423A GB7932142A GB7932142A GB2031423A GB 2031423 A GB2031423 A GB 2031423A GB 7932142 A GB7932142 A GB 7932142A GB 7932142 A GB7932142 A GB 7932142A GB 2031423 A GB2031423 A GB 2031423A
Authority
GB
United Kingdom
Prior art keywords
formula
compound
alkyl group
group
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7932142A
Other versions
GB2031423B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB7932142A priority Critical patent/GB2031423B/en
Publication of GB2031423A publication Critical patent/GB2031423A/en
Application granted granted Critical
Publication of GB2031423B publication Critical patent/GB2031423B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

Compounds of the formula (I> <IMAGE> (in which X represents HS- or a group R1R2N- wherein R1 and R2 which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms or a benzyl group and R3 represents a C3-7 alkyl group or a C3-7 cycloalkyl group) are prepared by reacting an alpha -ketoester of the formula (II> <IMAGE> (in which Alk represents an alkyl group) or a precursor thereof with a compound of the formula (III> <IMAGE> The precursor of the compound of formula (II) may be a mixture of isomeric enol esters <IMAGE> The compounds of formula (I) may be converted into compounds of formula VIII <IMAGE> in which R1 and R2 which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms, and R3 is as defined above.

Description

SPECIFICATION Production of Heterocyclic Compounds This invention relates to an improved process for the preparation of heterocyclic compounds, in particular triazinones and to the use thereof in the production of compounds which have pharmacological activity in particular imidazotriazinones.
In United Kingdom Patent Specification 1400999 there are described and claimed certain imidazo [5,1-f] triazinones which have pharmacological activity.
It is an object of the present invention to provide an improved process for the preparation of these compounds, which not only offers advantages in the number of process steps involved but also in the yield of the desired end product.
The present invention is particularly concerned with the preparation of triazinones of the formula (1)
in which X represents HS- or a group R1R2N- wherein R, and R2 which may be the same or different, represent hydrogen or a straight, or branched chain alkyl group containing from 1 to 4 carbon atoms or a benzyl group, and R3 represents a C37 alkyl group or a C37 cycloalkyl group; and their conversion into imidazo [5,1 -f]-1 ,2,4-triazin-4(3H)-ones.
According to one aspect of the invention we have found that triazinones of formula (I) may readily be prepared by the reaction of an a-ketoester of the general formula (ill):
in which R3 has the meanings given above and Alk is an aikyl group preferably having 1 to 3 carbon atoms, or a precursor thereof, with a compound of the formula (III):
in which X has the meanings given above.
It will be appreciated that the compound of formula (III) may exist in tautomeric forms, and it is intended that all such tautomers should be included.
When X represents -NR1R2, the above reaction may conveniently be effected in a suitable solvent, such as an alkanol e.g. ethanol, or dimethylformamide, with heating.
When X represents -SH, the reaction requires the presence of a base, e.g. sodium ethoxide, to proceed to completion and maybe carried out in two stages, if desired.
The compound of formula (III) may, if desired, be in the form of an acid addition salt, such as a bicarbonate, hydrochloride, nitrate or hydroiodide.
The reaction is particularly applicable to the production of compounds in which -NR1R2 is NH2.
Examples of the group Rs are propyl and isobutyl.
The conversion of the triazinones into imidazo [5,1-f]triazinones may be effected by processes generally described in United Kingdom Patent Specification 1400999. Thus triazinones of formula (i) in which X is R,R2Nmay be cyclised directly to the desired end product by heating with a cyclodehydrating agent such as phosphorus oxychloride or polyphosphoric acid. Triazinones of formula I in which R1 and/or R2 represents benzyl may be debenzylated on cyclisation.
Triazinones of formula (I) in which Xis a thiol group (-SH) may be converted into triazinones of formula (I) in which X represents R1R2N by S-alkylation with an alkyl halide (e.g. methyl iodide) and reaction of the alkylthio compound of formula (IV) so produced, in which Alk' is a lower alkyl group (e.g.
methyl) and R3 is as defined previously, with an amine of the formula R,R2NH or, in the case where X represents -NH2, with an ammonium salt (e.g. ammonium sulphate).
The a-ketoesters of general formula (II) may be prepared from an N-acylamino acid of the formula (V) R3CONHCH(CH3)COOH (V) by acylation with a suitable oxalyl halide in a manner similar to the Dakin-West reaction using for example an alkyl oxalyl chloride, in the presence of a suitable base such as pyridine or picoline optionally in the presence of a catalyst (e.g. dimethylaminopyridine) and with an additional solvent (e.g.
tetrahydrofuran), at reflux. The products of this reaction are the intermediate isomeric enol esters of the formulae (VI) and (VII).
These esters may then be hydrolysed, for example, with a mild acid or base to the a-ketoester of formula (II), or preferably they may be reacted with a compound of formula (III), particularly an aminoguanidine salt in which -NR1R2 is NH2, to give a triazinone of formula (I).
The N-acylamino acid of formula (V) may be prepared by the acylation of DL-alanine with an appropriate acylating agent for example an acid anhydride.
The present invention is particularly of interest for the production of 2-amino-5-methyl-7 propylimidazo[5, 1 -fi 1 ,2,4-triazin-4(3H)-one, which is disclosed and claimed in the United Kingdom Specification referred to above and which is obtained by the cyclisation of a compound of formula (I) in which R3 is propyl and X is -NH2. As disclosed in that specification this compound of formula (I) can be prepared from diethyloxalopropionate and aminoguanidine, however oniy in a six stage process and in low yield. According to the present process the appropriate compound of formula I may be prepared from a more readily available starting material, DI-alanine in fewer stages and in good yield.
Preparation of Starting Materials Preparation 1 Ethyl-3-butyramido-2-oxo-butyrate Ethyl oxalyl chloride (409.5 g) was added dropwise with stirring to a solution of butyrylalanine (238.5 g), anhydrous pyridine (355.5 g) and 4-dimethylaminopyridine (6 g) in anhydrous tetrahydrofuran (1 litre) at a rate sufficient to initiate refluxing. The mixture was heated to maintain a gentle reflux for 1 + hours, then cooled, diluted with water (1 litre) and extracted with ethyl acetate (3x500 ml). The extract was washed with water (2x250 ml) and dried (anhydrous sodium sulphate).
Removal of the solvent gave a mixture of enol esters as an orange syrup. This material contained polar impurities which were removed by column chromatography in two batches. The crude product was adsorbed onto silica gel (2x700 g) and eluted with cyclohexane-ethyl acetate (3:1) to give the purified enol esters (293 g).
This material was dissolved in absolute ethanol (270 ml) and heated at reflux in the presence of sodium bicarbonate (66 g) for 2 hours. The mixture was cooled and sodium bicarbonate removed by filtration. The filtrate was concentrated to give the a-ketoester as a golden-yellow syrup (200 g).
Purification of the product could be effected by chromatography on a column of silica gel (cyclohexane-ethyl acetate,3:1e1 :1), to give a pale yellow viscous oil that crystallised on trituration with pentane-ether at ca. 100. Recrystallisation from pentane-ether gave the title compound m.p.
46.5--49.50.
Preparation 2 Ethyl-3-isovaleramido-2-oxo-butyrate Ethyl oxalyl chloride (212 g) was added dropwise with stirring to a solution of isovalerylalanine (136 g) and pyridine (186.5 g) in anhydrous tetrahydrofuran (500 ml) at a rate sufficient to initiate refluxing. The reaction mixture was stirred and heated at reflux for 5 hours. The cooled reaction mixture was treated with water (1000 ml) and extracted with ethyl acetate (4x400 ml). The combined organic extracts were washed with water (3x200 ml) and dried (anhydrous sodium sulphate). Removal of solvent provided a yellow syrup which was evaporated with benzene (2x200 ml) to yield the isomeric enol esters of the title compound.
These were dissolved in absolute ethanol (400 ml) and heated at reflux in the presence of sodium bicarbonate (70 g) for 3 hours. After cooling, the sodium bicarbonate was filtered off and the filtrate was evaporated in vacuo. The resultant residue was taken up in ethyl acetate (500 ml) and washed with water (4x 100 ml). The dried (anhydrous sodium sulphate) ethyl acetate phase was evaporated in vacuo to provide crude a-ketoester as a golden syrup, 147 g.
Purification using a similar procedure to that described in Preparation 1 gave the title compound, m.p. 5253.5 (from pentane-ether).
Example 1 N-[1 -(3-Ami no-2,5-dihydro-5-oxo-1 ,2,4-triazin-6-yl)-ethyl]-butyra mide Aminoguanidine bicarbonate (2.4 g) was suspended in a solution of ethyl 3-butyramido-2-oxobutyrate (3.8 g) in absolute ethanol (40 ml) and the mixture was heated under reflux for 5 hours. During this period aminoguanidine bicarbonate gradually dissolved and a new product precipitated as a white solid. The mixture was cooled and the solid (2.62 g) collected and taken up in 2N hydrochloric acid (30 ml). The solution was filtered to remove a small amount of undissolved solid, then adjusted to pH 8 by adding solid sodium carbonate. The triazinone separated as a white solid which was collected, washed with water and dried in vacuo at 1000 to give material m.p. 3080 (dec.), (2.0 g) (50% approx.).
Example 2 N-[1 -(3-Mercapto-4.5-dihydro-5-oxo-l .2.4-triazin-6-yl )ethyl]-butyra mide (a) Ethyl 3-Butyramido-2-oxo-butyrate, Thiosemicarbazone A mixture of ethyl 3-butyramido-2-oxo-butyrate (30 g) and thiosemicarbazide (8 g) in absolute ethanol (100 ml) was added under reflux for 4 hours. The mixture was cooled to 0 and the thiosemicarbazone crystallised out. This was collected and the filtrate concentrated to give a second crop which was combined with the first to give a total of 8.3 g. This material was used in the next stage without further purification.
(i) In a similar manner was prepared ethyl 3-isovaleramido-2-oxo-butyrate, thiosemicarbazone, m.p. 1 79-181 0 (4.6 g) from ethyl 3-isovaleramido-2-oxo-butyrate (5.75 g) and thiosemicarbazide (2.3 g).
(b) N-[1 -(3-Mercapto-4,5-dihydro-5-oxo-1 ,2,4-triazin-6-yl)-ethyl] butyra mide Ethyl 3-butyramido-2-oxo butyrate, thiosemicarbazone (8.3 g) was added to a solution of sodium ethoxide (from 0.63 g of sodium) in absolute ethanol (250 ml) and the mixture heated under reflux for 2 hours, and then cooled. Ethanol was removed in vacuo and the residual solid dissolved in water (15 ml). The solution was acidified with 2N hydrochloric acid and the solid that precipitated was collected and recrystallised from ethyl acetate to give the mercaptotriazinone, m.p. 21 3-21 50 (4.34 g).
(i) In a similar manner was prepared N-[1 -(3-mercapto-4,5-dihydro-5-oxo-1 ,2,4-triazin-6- yl)ethyl]-3-methylbutyramide (10.0 g) m.p. 195--1960 (from ethyl acetate) from ethyl 3isovaleramido-2-oxo-butyrate, thiosemicarbazone (16.56 g).
Example 3 N-[1 -(3-Methylthio-4,5-dihydro-5-oxo-1 ,2,4-triazin-6-yl)ethyl] butyramide A solution of N-[1 -(3-mercapto-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl)ethyl]butyramide (4.0 butyra m ide (4.0 g), methyl iodide (2 ml) and 85% potassium hydroxide (1.28 g) in ethanol (70 ml) and water (35 ml) was stirred at room temperature for 4 hours. The solvent was removed in vacuo and the pale yellow residue partitioned between water (20 ml) and ethyl acetate (150 ml). The ethyl acetate layer was separated and the aqueous phase extracted again with ethyl acetate (4x 100 ml). The extracts were combined dried (Na2SO4) and evaporated in vacuo to give a pale yellow solid. Recrystallisation from ethanol-ethyl acetate furnished the methylthiotriazinone, m.p. 180--1830 (2.55 g).
(i) In a similar manner was prepared N-[1 -(3-methylthio-4,5-dihydro-5-oxo-1 ,2,4-triazin-6- yl)ethyl]-3-methylbutyramide (1.0 g) m.p. 193--1940 (from ethyl acetate) from N-[1-(3-mercapto 4,5-dihydro-5-oxo- 1 ,2,4-triazin-6-yl )ethyl]-3-methylbutyramide (2.0 g).
Example 4 N-[1 -(3-Amino-2,5-dihydro-5-oxo-1 ,2,4-triazin-6-yl)ethyl]-butyra mide Ethyl oxalyl chloride (67 ml) was added over 30 minutes to a stirred solution of N-butyrylalanine (47.7 g), 4-dimethylaminopyridine (1.0 g), and pyridine (73 ml) in tetrahydrofuran (200 ml). The mixture was stirred under reflux for 3h and then allowed to cool overnight. The mixture was diluted with water (200 ml), extracted with ethyl acetate (3 x 00 ml) and the extracts were washed with water (2 x 100 ml), dried (MgSo4), and the solvent removed in vacuo at 400C to give the (E)- and (Z)- isomers of 4-[ 1 -[(propylcarbonyl)amino]ethylidene]-3-oxa-2-oxopentanedioic acid, diethyl ester as an orange oil (104 g).N m.r. T(CDC13) ca 1.0 (1 H, br, NH), 5.5-6.0 (4H, 2xq, CO2CH2CH3), 7.3 and 7.65 (3H, 2xs, C=CCH3), 7.48 (t, CH3CH2CH2CO),8.25 (m, CH3CH2CH2CO) and 8.5-9.1 (m, CO2CH2CH3 plus CH3CH2CH2CO).
The oil was added to a suspension of aminoguanidine bicarbonate (81.6 g) in methanol (600 ml) and the mixture was heated under reflux for 5h. During this period aminoguanidine bicarbonate gradually dissolved and a new product precipitated as a white solid. The mixture was allowed to cool overnight and the solid was filtered off, washed with methanol (150 ml), and dissolved in 2N hydrochloric acid (450 ml). The solution was filtered through a diatomaceous earth to remove a small amount of precipitated solid and then adjusted to pH8 by adding 70% sodium hydroxide solution. The triazinone separated as an off-white solid which was filtered off, washed with water, and dried in vacuo at 800C. Yield=37.0 g; m.p. 309--3100C (decomp).
Example 5 2-Amino-5-methyl-7-propyl-imidazo[5,1 -f] 1 ,2,4-triazin-4(3H)-one N-[1 -(3-Amino-2,5-dihydro-5-oxo-1 ,2,4-triazin-6-yl)ethyl]butyramide (37.0 g) was added to stirred polyphosphoric acid (260 g) at 900C over 30 minutes and then the mixture was stirred at 1 5000 for 2h. The mixture was allowed to cool overnight, then warmed to 1000C and poured into a mixture of ice (370 g) and water (370 g). The solution was adjusted to pH6 by adding 70% sodium hydroxide solution (ca. 230 ml). The precipitated solid was filtered off and was dissolved in 1 N hydrochloric acid (740 ml).The solution was clarified and adjusted to pH8 by adding 2N sodium hydroxide solution to give the imidazo[5,1 -f] 1 ,2,4-triazin-4(3H)-one as an off-white solid which was filtered off, washed with water, and dried in vacuo at 800C. Yield=30.2 g; m.p. 2660C.
Example 6 N-[1 -(3-N'-benzyl-N'-methylamino-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl)ethyl]-3- methylbutyramide l-amino-2-benzyl-2-methylguanidinium hydroiodide (7.65 g) and ethyl-3-isovaleramido-2-oxobutyrate (5.75 g) were heated in absolute ethanol (20 ml) under reflux for 3h. The resultant brown solution was concentrated in vacuo and the residue was dissolved in ethyl acetate: water (50:50, total 100 ml). The aqueous layer was separated, basified with 8% sodium bicarbonate solution and extracted with ethyl acetate (8x20 ml). The latter extracts and the above ethyl acetate phase were combined and evaporated in vacuo to give a brown oil. The oil was redissolved in ethyl acetate (150 ml) and the solution treated with charcoal, filtered and concentrated.Dilution with anhydrous ether gave a brown oil which solidified upon stirring under anhydrous ether. The ether was removed in vacuo at 250 to provide 6.65 g of a light brown solid, m.p. ca. 1100. This solid was dissolved in ethanol and purified by filtration through a column of silica gel followed by recrystallisation from ethanol-ethyl acetate to give white crystals m.p. 1 69-1 700.
Example 7 5-Methyl-2-methylamino-7-(2-methyl)propylimidazo[5, I -f]-1 ,2,4-triazin-4(2H)-one, Hydrochloride Polyphosphoric acid (6.0 g) was heated to 750C and N-[1-(3-N'-benzyl-N'-methylamino-4,5- dihydro-5-oxo-1 ,2-4-triazin-6-yI)-3-methyl butyramide was added. The mixture was heated at 1201300C for 8 h with occasional stirring and then cooled to room temperature and neutralised with 8% sodium bicarbonate solution. The buff precipitate was collected by filtration (0.52 g) and converted into a hydrochloride salt m.p. 276--2800 (decomp).
Example 8 N-[1 -(3-N'-benzyl-N'-methylamino-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl)ethyl]-3- methylbutyramide A mixture of N-[1 -(3-methylthio-4,5-dihydro-5-oxo- 1 ,2,4-triazin-6-yl)ethyl]-3-methylbutyramide (0.5 g) was heated with N-benzyl-N-methylamine (0.224 g) in refluxing n-butanol for 4 days. Removal of solvent in vacuo left a brown oil which was absorbed onto a column of silica gel (20 g, Merck Kieselgel 60). Elution with 1 :10 benzene: ethyl acetate foliowed by concentration of the appropriate fractions provided the title compound, 0.35 g m.p. 176--80 (ethyl acetate-ethanol).

Claims (12)

Claims
1. A process for the preparation of triazinones of the general formula (I):-
(in which X represents HS- or a group R1R2N- wherein R and R2 which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms or a benzyl group and R3 represents a C3~7 alkyl group or a C3~7 cycloalkyl group which comprises reacting an a-ketoester of the general formula (Il):-
(in which R3 has the meaning given above and Alk represents an alkyl group) or a precursor thereof with a compound of the general formula (III)::--
(in which X has the meaning given above) optionally in the form of an acid addition salt.
2. A process as claimed in claim 1 in which -NR1R2 is -NH2.
3. A process as claimed in claim 1 or claim 2 in which R3 is propyl or isobutyl.
4. A process as claimed in any of claims 1 to 3 in which X represents -NR1R2 and the reaction is carried out in a solvent with heating.
5. A process as claimed in any of claims 1 to 4 in which the -ketoester of the general formula Il has been prepared by the hydrolysis of isomeric enol esters of the formulae:
in which R3 and Alk have the meanings given in claim 1.
6. A process as claimed in any of claims 1 to 4 in which as precursor of the a-ketoester, there is used the isomeric enol ester mixture as defined in claim 5.
7. A process as claimed in claim 5 or claim 6 in which the isomeric enol ester mixture is made by reaction of an N-acylamino acid of the formula (V) R3CONHCH(CH3)COOH (V) in which R3 has the meaning given in claim 1 with an alkyl oxalyl chloride.
8. A process as claimed in claim 1 substantially as herein described with reference to the Examples.
9. Compounds of formula (I) when prepared by a process as claimed in any of claims 1 to 8.
10. A process for the preparation of compounds of the general formula (VIII):-
in which R, and R2 which may be the same or different represent hydrogen or a straight or branched chain alkyl group containing from 1 to 4 carbon atoms and R3 has the meaning given in claim 1, in which a compound of formula (I) defined in claim 1 is cyclised by heating with a cyclo-dehydrating agent, when X represents a group R1R2N-, in which R, and R2 have the meanings given in claim 1 or when X is a thio group (-SH) conversion to an alkylthio compound, and reaction of the alkylthio compound with an amine of the formula R,R2NH in which R1 and R2 have the meanings given in claim 1, wherein the compound of formula (I) has been made by the process of claims 1 to 8.
11. A process as claimed in claim 10 substantially as herein described with reference to the Examples.
12. Compounds of formula VIII when prepared by a process as claimed in claim 10 or claim 11.
GB7932142A 1978-09-18 1979-09-17 Production of heterocyclic compounds Expired GB2031423B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7932142A GB2031423B (en) 1978-09-18 1979-09-17 Production of heterocyclic compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7837215 1978-09-18
GB7932142A GB2031423B (en) 1978-09-18 1979-09-17 Production of heterocyclic compounds

Publications (2)

Publication Number Publication Date
GB2031423A true GB2031423A (en) 1980-04-23
GB2031423B GB2031423B (en) 1982-11-24

Family

ID=26268892

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7932142A Expired GB2031423B (en) 1978-09-18 1979-09-17 Production of heterocyclic compounds

Country Status (1)

Country Link
GB (1) GB2031423B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016147659A1 (en) * 2015-03-16 2016-09-22 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative

Also Published As

Publication number Publication date
GB2031423B (en) 1982-11-24

Similar Documents

Publication Publication Date Title
US4308384A (en) Production of triazinones
US4618610A (en) Triazine derivatives, and pharmaceutical compositions comprising the same
KR910005850B1 (en) Process for the preparation of imidazo (1,5-a) pyrimidien derivatives
US4841068A (en) 3-hydroxy pyrazole derivatives
KR830001967B1 (en) Method for preparing benzodiazepines derivatives
GB2031423A (en) Production of Heterocyclic Compounds
US4555571A (en) Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters
US4634769A (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
US5480991A (en) 2-Alkoxy-4-hydroazinopyrimidine compounds and their use in the preparation of 5-alkoxy-1,2,4-triazolo[4,3-c]pyrimidine-3(2H)-thione compounds
US4077956A (en) 5-Substituted derivatives of dipyrazolo[1,5-a:4&#39;,3&#39;-e]pyrazine-6-carboxylic acids and esters
US4985563A (en) Process for the preparation of 6-piperidino-2,4-diamino pyrimidine-3-oxide
US3390150A (en) Process for the preparation of 1-(beta-hydroxyethyl)-5-nitroimidazole-2-carboxylic acid gamma-lactone
Heyman Preparation of isatoates from isatoic anhydride
US3644392A (en) 1-substituted-5-nitroimidazole-2-carboximidates
US4066645A (en) Derivatives of pyrazolo [1,5-a]pyrido[3,4-e]pyrimidine
US3736316A (en) 1,2,5-benzotriazepin-4-ones and their preparation
JPH08505410A (en) 2-Alkoxy-4-hydrazinopyrimidine compounds and their use in the preparation of 5-alkoxy-1,2,4-triazolo [4,3-c pyrimidine-3 (2H) -thione compounds
SK77893A3 (en) Process for preparing imidazopyridines
US3951967A (en) 7-Mercapto(or thio)-benzothiadiazine products
US3472847A (en) Conversion of pyrazinoylcyanamides to pyrazinoylguanidines
PL164340B1 (en) Method of obtaining novel benzothiazine derivatives
US4024136A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
HU195485B (en) Process for producing aromatic carboxylic acid derivatives and -carboxamide derivatives
JPH07300480A (en) Improved process for producing 2-amino-6-chloropurine and 2-acylamino-6-chloro-purine
JP3538889B2 (en) Method for producing alkylthioacetamide

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee